BioLife Solutions Inc (BLFS)

Pretax margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Earnings before tax but after interest (EBT)	US$ in thousands	-20,222	-66,258	-144,827	-29,026	-1,281
Revenue	US$ in thousands	97,977	142,625	160,996	118,837	48,087
Pretax margin		-20.64%	-46.46%	-89.96%	-24.43%	-2.66%

December 31, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $-20,222K ÷ $97,977K
= -20.64%

BioLife Solutions Inc's pre-tax margin has exhibited significant fluctuation over the past five years. The company's pre-tax margin was negative in all years, indicating that its operating expenses and other costs exceeded its pre-tax profits during these periods.

In December 31, 2020, BioLife Solutions had a pre-tax margin of -2.66%, which indicates that the company was able to generate a small profit before taxes relative to its total revenue. However, the pre-tax margin deteriorated sharply in December 31, 2021, plunging to -24.43%, reflecting a substantial decrease in profitability and possibly an increase in operating expenses.

The situation worsened further in December 31, 2022, when the pre-tax margin plummeted to -89.96%, signaling a significant financial loss before taxes. This drastic decline may raise concerns about the company's financial management and sustainability.

BioLife Solutions managed to improve its pre-tax margin in December 31, 2023, to -46.46%, but it remained negative, indicating ongoing challenges in generating profits relative to its total revenue.

The most recent data point, December 31, 2024, shows a pre-tax margin of -20.64%, representing a partial recovery from the lowest point in 2022 but still reflecting a profitability struggle for the company.

Overall, the trend of negative pre-tax margins over the years raises questions about BioLife Solutions Inc's operational efficiency, cost control, and ability to generate sustainable profits in the long term. Investors and stakeholders may need further insights into the company's strategies and performance measures to assess its financial health and future prospects.